
    
      This is a single-blind multicentre controlled randomized trial with consecutive recruitment.
      Randomization list by blocks will be available. Group comparison will be made between active
      therapies including TPEP added to conventional MABT (Intervention) or MABT alone (Control).
      Active therapy will last 10 consecutive daily sessions in both groups.

      Primary outcome

      Efficacy comparison on change in:

      a.arterial oxygenation (as assessed by PaO2/FiO2 ratio and/or SatO2 index)

      Secondary outcomes

      Efficacy comparison on change in:

        1. Sputum characteristics

        2. Daily sputum volume

        3. Perceived sensation

        4. Lung functions (as assessed by spirometry and RM strength)
    
  